Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show

Deciphera Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences


Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, today announced that members of the management team will present at the following investor conferences:

A live webcast of both events will be available on the "Events and Presentations" page in the "Investors" section of the Company's website at https://investors.deciphera.com/news-events/events-presentations. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.

About Deciphera Pharmaceuticals

Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and/or durability of response to existing cancer therapies. Our small molecule drug candidates are directed against an important family of enzymes called kinases, known to be directly involved in the growth and spread of many cancers. We use our deep understanding of kinase biology together with a proprietary chemistry library to purposefully design compounds that maintain kinases in a "switched off" or inactivated conformation. These investigational therapies comprise tumor-targeted agents designed to address therapeutic resistance causing mutations and immuno-targeted agents designed to control the activation of immunokinases that suppress critical immune system regulators, and agents designed to inhibit reprogramming of cancer cell metabolism. We have used our platform to develop a diverse pipeline of tumor-targeted, immuno-targeted, and metabolism-targeted drug candidates designed to improve outcomes for patients with cancer by improving the quality, rate and/or durability of their responses to treatment


These press releases may also interest you

at 16:10
MeridianLink Announces First Quarter 2024 Financial Results Conference Call
MeridianLink, Inc. , a leading provider of modern software platforms for financial institutions and consumer reporting agencies, will release its first quarter 2024 financial results after market close on Tuesday, May 7, 2024, with a conference call...

at 16:10
Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2024 Financial Results and Pipeline Update
Arcus Biosciences , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will host a conference call and webcast on...

at 16:10
PagerDuty Announces 2024 PagerDuty On Tour Event Series
PagerDuty, Inc. , a global leader in digital operations management, today announced speakers for its PagerDuty On Tour 2024, a series of global events convening business leaders, technologists, DevOps practitioners, site reliability engineers and...

at 16:06
Expedia Cruises Drops Anchor in Camillus
Planning a vacation has just become a lot easier for families in Syracuse with the announcement of a new Expedia Cruises location, now open at 240 Township Blvd Suite 50, located at Township 5....

at 16:05
Coupang to Announce First Quarter 2024 Results on May 7, 2024
Coupang, Inc. will release its first quarter 2024 financial results on Tuesday, May 7, 2024 (Eastern Time). The release will be available after U.S. market close and an accompanying live webcast will begin at 5:30 PM Eastern Time the same day. The...

at 16:05
Biote Schedules First Quarter 2024 Financial Results Release and Conference Call
biote Corp. ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced the Company will provide first quarter financial...

More news about Science and technology...


News published on and distributed by: